| Hans-Günter Meyer-Thompson | Cannabis als Medizin
Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial
Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial
Freeman, Tom P et al.
The Lancet Psychiatry, Volume 0, Issue 0
www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(20)30290-X/fulltext